Sort
53,477 grants matching “addiction”
Training in the Science of Co-Occurring Disorders
$384,612Alan Jeffrey Budney · Dartmouth College · T32 · FY2016 · DA
Neural circuitry of safety, fear and reward cue discrimination
$384,605Susan Sangha · Purdue University · R01 · FY2020 · MH
Amoeboid Membrane Dynamics in Prostate Cancer
$384,579Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2014 · CA
Functional Imaging of Mu and Delta Opioid Receptors In Vivo: Receptor Dynamics
$384,565Brigitte L Kieffer · University Of California Los Angeles · P50 · FY2011 · DA
NEUROCOGNITIVE PREDICTORS OF SMOKING CESSATION
$384,557Andrey P. Anokhin · Washington University · RC1 · FY2010 · DA
Analysis of hormones in nonhuman primate samples using liquid chromatography-tandem triple quadrupole mass spectrometry (LC-MS/MS)
$384,550David William Erikson · Oregon Health & Science University · S10 · FY2019 · OD
Neural circuitry of safety, fear and reward cue discrimination
$384,548Susan Sangha · Purdue University · R01 · FY2021 · MH
Unmet needs for specific subsets of EGFR mutated lung cancer
$384,536Daniel Botelho Costa · Beth Israel Deaconess Medical Center · R37 · FY2024 · CA
Microglial pruning of dopamine receptors and opioid abuse.
$384,511Staci D Bilbo · Duke University · R01 · FY2025 · DA
Multidisciplinary Training in the Biology of Addiction
$384,508Brian A McCool · Wake Forest University Health Sciences · T32 · FY2012 · AA
TREATMENT OF COCAINE ABUSING WOMEN AT HIGH RISK FOR HIV INFECTION
$384,496Charles Dackis · University Of Pennsylvania · P60 · FY2011 · DA
Affective and Inflammatory Reactivity to Pain in Opioid Use Disorder
$384,449Rebecca Kathryn McHugh · Mclean Hospital · R01 · FY2019 · DA
Validating SER-014, a TRPV1 antagonist, to treat endometriosis
$384,418Kumaril Bhargava · Serentrix, Llc · R41 · FY2024 · HD
Research Fellowship in Substance Abuse Disorder
$384,409Frances Rudnick Levin · Columbia University Health Sciences · T32 · FY2015 · DA
Linking Services to Patient Needs for Improved Outcomes
$384,382Deni Carise · Treatment Research Institute · R01 · FY2006 · DA
Fetal and Infant Neurobehavior in Opiate Dependent Women
$384,377Lauren M Jansson · Johns Hopkins University · R01 · FY2008 · DA
Novel brain penetrant metabolic inhibitors to treat MYC-driven medulloblastoma
$384,361Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2018 · NS
Novel brain penetrant metabolic inhibitors to treat MYC-driven medulloblastoma
$384,361Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2019 · NS
METABOLIC REGULATORS OF TUMOR CELL GROWTH
$384,354Ralph J Deberardinis · Ut Southwestern Medical Center · R01 · FY2016 · CA
COCAINE-INDUCED SYNAPTIC PLASTICITY IN LIMBIC BRAIN REGIONS
$384,352Virginia M Pickel · Rockefeller University · P60 · FY2008 · DA
Novel brain penetrant metabolic inhibitors to treat MYC-driven medulloblastoma
$384,346Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2020 · NS
Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs
$384,300Frank J. Slack · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
Optogenetic investigations of motivational circuits in rats and mice
$384,253Satoshi Ikemoto · National Institute On Drug Abuse · ZIA · FY2017 · DA
Neural mechanisms involved in the development of addiction-like symptoms
$384,253Satoshi Ikemoto · National Institute On Drug Abuse · ZIA · FY2017 · DA
Identifying topiramate's therapeutic mechanisms through motivational salience
$384,243Jason D Robinson · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · DA